BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21669268)

  • 21. Evolution of 11beta-hydroxysteroid dehydrogenase-type 1 and 11beta-hydroxysteroid dehydrogenase-type 3.
    Baker ME
    FEBS Lett; 2010 Jun; 584(11):2279-84. PubMed ID: 20350543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
    Latif SA; Pardo HA; Hardy MP; Morris DJ
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
    Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.
    Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM
    J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of cortisol and 11beta-hydroxysteroid dehydrogenase enzymes in the development of porcine (Sus scrofa domestica) ovarian follicles and cysts.
    Sunak N; Green DF; Abeydeera LR; Thurston LM; Michael AE
    Reproduction; 2007 Jun; 133(6):1149-58. PubMed ID: 17636169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?
    Seckl JR
    Front Neuroendocrinol; 1997 Jan; 18(1):49-99. PubMed ID: 9000459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the male reproductive tract.
    Waddell BJ; Hisheh S; Krozowski ZS; Burton PJ
    Endocrinology; 2003 Jul; 144(7):3101-6. PubMed ID: 12810566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
    Abdallah BM; Beck-Nielsen H; Gaster M
    Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterisation of the cancer-associated glucocorticoid system: key role of 11β-hydroxysteroid dehydrogenase type 2.
    Cirillo N; Morgan DJ; Pedicillo MC; Celentano A; Lo Muzio L; McCullough MJ; Prime SS
    Br J Cancer; 2017 Sep; 117(7):984-993. PubMed ID: 28797028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action.
    Seckl JR
    Curr Opin Pharmacol; 2004 Dec; 4(6):597-602. PubMed ID: 15525550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure.
    Cooper MS; Rabbitt EH; Goddard PE; Bartlett WA; Hewison M; Stewart PM
    J Bone Miner Res; 2002 Jun; 17(6):979-86. PubMed ID: 12054173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP; Ebert B; Martin HJ; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):104-8. PubMed ID: 19022342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.
    Garbrecht MR; Schmidt TJ; Krozowski ZS; Snyder JM
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E653-60. PubMed ID: 16263772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.
    Kratschmar DV; Vuorinen A; Da Cunha T; Wolber G; Classen-Houben D; Doblhoff O; Schuster D; Odermatt A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):129-42. PubMed ID: 21236343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11 beta-Hydroxysteroid dehydrogenase in the rat inner ear.
    Ten Cate WJ; Monder C; Marandici A; Rarey KE
    Am J Physiol; 1994 Feb; 266(2 Pt 1):E269-73. PubMed ID: 8141286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2.
    Ma X; Lian QQ; Dong Q; Ge RS
    Toxicology; 2011 Jul; 285(3):83-9. PubMed ID: 21515335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.
    Diederich S; Scholz T; Eigendorff E; Bumke-Vogt Ch; Quinkler M; Exner P; Pfeiffer AF; Oelkers W; Bähr V
    Horm Metab Res; 2004 Jun; 36(6):423-9. PubMed ID: 15241735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human and rat 11β-hydroxysteroid dehydrogenases activities by bisphenol A.
    Guo J; Yuan X; Qiu L; Zhu W; Wang C; Hu G; Chu Y; Ye L; Xu Y; Ge RS
    Toxicol Lett; 2012 Nov; 215(2):126-30. PubMed ID: 23069880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.